CYCN vs NDSN · $8.6M cap vs P/E 31, rev $817.7M
Cyclerion Therapeutics Inc (CYCN) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
CYCN currently screens at market cap $8.6M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the CYCN and NDSN stock pages for the full models.
Not investment advice.